Patent · US Expired

Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair

US7906110B2 · kind B2 · utility

29Cited by
41References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 25, 2005
Grant dateMar 15, 2011
Priority date
Expiry dateSep 2, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to preparation of stem cell and physiologically acceptable matrix compositions. Compared with previous tissue engineering materials, the stem cell-matrix compositions of the present invention do not require long-term incubation or cultivation in vitro prior to use in vivo applications. The stem cells can be from numerous sources and may be homogeneous, heterogeneous, autologous, and/or allogeneic in the matrix material. The stem cell-matrix compositions provide point of service utility for the practitioner, wherein the stem cells and matrix can be combined not long before use, thereby alleviating costly and lengthy manufacturing procedures. In addition, the stem cells offer unique structural properties to the matrix composition which improves outcome and healing after use. Use of stem cells obtained from muscle affords contractility to the matrix composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.